HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

1- (3- C- ethynylribopentofuranosyl)cytosine

structure given in first source
Also Known As:
1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine; 3'-ethynylcytidine; 3-C-ethynyl-cytidine; ECyd cpd; TAS 106; TAS-106
Networked: 26 relevant articles (3 outcomes, 5 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Matsuda, Akira: 11 articles (01/2017 - 01/2002)
2. Fukushima, Masakazu: 8 articles (01/2017 - 01/2002)
3. Sasaki, Takuma: 7 articles (05/2009 - 01/2002)
4. Kazuno, Hiromi: 5 articles (05/2009 - 04/2002)
5. Wataya, Yusuke: 4 articles (01/2017 - 01/2002)
6. Naito, Tomoharu: 3 articles (01/2017 - 01/2002)
7. Mita, Akira: 3 articles (05/2012 - 06/2010)
8. Shimamoto, Yuji: 3 articles (06/2007 - 04/2002)
9. Asanuma, Taketoshi: 3 articles (05/2007 - 12/2004)
10. Iizuka, Daisuke: 3 articles (05/2007 - 12/2004)

Related Diseases

1. Neoplasms (Cancer)
2. Ovarian Neoplasms (Ovarian Cancer)
3. Squamous Cell Neoplasms (Squamous Cell Cancer)
4. Nasopharyngeal Neoplasms (Cancer of the Nasopharynx)
5. Lung Neoplasms (Lung Cancer)

Related Drugs and Biologics

1. DNA-Directed RNA Polymerases (RNA Polymerase)
2. Platinum
3. Carboplatin (JM8)
4. Drug Combinations
5. Nucleosides
6. Cisplatin (Platino)
7. RNA (Ribonucleic Acid)
8. 1- (3- C- ethynylribopentofuranosyl)cytosine
9. Uridine Kinase
10. Proteins (Proteins, Gene)

Related Therapies and Procedures

1. Intravenous Administration
2. Drug Therapy (Chemotherapy)
3. Aftercare (After-Treatment)